1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden.

Saved in:
Bibliographic Details
Title: 1735TiP NETTER-3: A phase III study of [177Lu]Lu-DOTA-TATE in patients with newly diagnosed, grade 1 and grade 2 (Ki-67<10%) advanced gastroenteropancreatic neuroendocrine tumors and high disease burden.
Authors: Singh, S.1 (AUTHOR), Capdevila, J.2 (AUTHOR), Halfdanarson, T.R.3 (AUTHOR), Halperin, D.4 (AUTHOR), Herrmann, K.5 (AUTHOR), Pavel, M.E.6 (AUTHOR), Xu, J.7 (AUTHOR), Pathak, D.8 (AUTHOR), Kunz, P.L.9 (AUTHOR)
Source: Annals of Oncology. 2025 Supplement 2, Vol. 36, pS1020-S1020. 1p.
Database: Academic Search Ultimate
Description
ISSN:09237534
DOI:10.1016/j.annonc.2025.08.2363